A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)
Clinical trial NCT00770159 · COMPLETED
Trial details
- NCT number
- NCT00770159
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2005-06-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.